Home Terms & Conditions About IFF Entrepreneurs & Venture Capitalists Resources Ask IFF Contact Us
 
Investment Strategy
Indiana Opportunity
Life Sciences Opportunity
Indiana Expertise
Fund Management
Venture Capitalists

About IFF

INDIANA'S AREAS OF EXPERTISE

More specifically, Indiana possesses identifiable expertise in the following eight select areas, as documented by BioCrossroads:

CARDIOVASCULAR

The cardiovascular pharmaceuticals and devices market produces worldwide sales of more than $97 billion. It focuses on the treatment and understanding of the heart and circulatory system to diagnose and fix disorders of the heart and blood vessels. Key players in the region include Guidant, Cook Group, Rose-Hulman, Purdue University and Indiana University.

NEUROSCIENCE

The neuroscience sub-sector encompasses the diagnosis, treatment and understanding of the central nervous system in humans and animals. Life sciences companies such as Eli Lilly are placing considerable emphasis on this area, which had worldwide sales of $59.2 billion in 2001. Key players in the region include the Stark Neurosciences Research Institute at the Indiana University School of Medicine and Purdue University's Center for Paralysis Research and Institute for Applied Neurology.

EVIDENCE-BASED MEDICINE

This sub-sector focuses on enhancing healthcare outcomes while reducing costs by providing healthcare professionals and patients with the knowledge base, genetic analysis and drug discovery regimes to enable the personalization of medicine. Key players in the region include the Regenstrief Institute and Indiana University's Pervasive Computing Research Initiative.

PROTEIN ANALYSIS

The protein analysis sub-sector focuses on understanding disease and wellness through applying knowledge of proteins. This sub-sector has gained considerable interest in the region, already benefiting from substantial levels of investment. Key players in the region include the Indiana Proteomics Consortium, the Indiana Genomics Initiative, Purdue's Bioscience and Biomedical Engineering Centers and the Indiana University Center for Bioinformatics.

BIOSENSORS

The biosensors sub-sector focuses on the integration of nano and micro-scale components and molecules to activate the delivery of drugs and to aid in drug discovery. Key players in the region include Purdue's Birck Nanotechnology Center and Biomedical Engineering Center, Indiana University's Biomechanics and Biomaterials Research Center and the biomedical research and development at Rose-Hulman.

CANCER

This sub-sector focuses on applying knowledge to the prevention, detection, diagnosis and treatment of cancers. Key players in the region include the IU School of Medicine, the IU Cancer Center, the Walther Oncology Center, the Radiation and Cancer Biology Research Labs, the Breast Care and Research Center, the Center of Excellence in Biomedical Imaging, the Purdue Cancer Center, Indiana University's Midwest Proton Radiotherapy Institute, and the Radiology Imaging Center at the National Institute of Fitness and Sport.

AGRI-BIO

Agri-Bio is the use of bio-materials such as improved genes, proteins, sugar compounds and bioengineering to improve production of crops, farm animals and beneficial insects. Within agri-bio, plant biotechnology alone generates worldwide sales of $3 billion. Key players in the region include Purdue's Agricultural Genomics Initiative, Dow AgroSciences, Elanco Animal Health and the Indiana University Genomics Database.

SPORTS CENTERED LIFE SCIENCES

This sub-sector, which exceeds $71 billion annually, focuses on improving sports performance and injury recovery via innovation in medicines, devices, treatments, procedures and nutrients. Key players in the region include the National Institute for Fitness and Sport, the American College of Sports Medicine and Ball State's Human Performance Lab.